For this current systemic review and meta-analysis, Literature has been reviewed from January 2008 to March 2019 focusing on the incidence of hemoptysis after cryoballoon ablation for AF ablation
17/50, 36%) with commonest pathogen Pseudomonas aeruginosa and fi nally fungus (11/50, 22%) (three cases with Candida albicans and eight with Candida non-albicans). Mean time of identifi cation of positive urine culture 14±4,7 days post transplantation. Preliminary statistical analysis revealed signifi cant relation of positive urine culture with female gender (Pearson x2, p=0,043) and cold ischemia time (non-parametric test Mann Whitney U, p=0,005). Further analysis of urinary tract infection presented with pyuria did not show signifi cant relations with the parameters examined. Conclusions: Positive urine cultures were observed in 32,7% of renal transplant recipients with commonest pathogens Enterococcus faecalis and Pseudomonas aeruginosa. These fi ndings demonstrate signifi cant relation with female gender and cold ischemia time. POSTER BOARD NUMBER P1 -249 ETIOLOGICAL AGENTS OF FUNGAL INFECTIONS 1164 IN PATIENTS AFTER SOLID ORGAN TRANSPLANTATIONS (SOT) -FUNGAL STRAINS AND THEIR SUSCEPTIBILITY TO ANTIFUNGAL DRUGS.Fungal infection is one of the severe complication in patients undergoing solid organ transplantations. Aim: The aim of the study was to evaluate species distribution and antifungal susceptibilities of fungal isolates taken from patients after -SOT. Material and methods: The study included samples of urine, blood, systemic fl uids and the swabs of the post-operative wounds, haematomas, drains taken from patients after kidney, liver or simultaneous pancreas-kidney transplantation hospitalized in . All cultured specimens were isolated by using Sabouraud medium with antibacterial protection using chloramphenicol and gentamicin (bioMerieux, France or Oxoid, England). Yeast-like fungi was incubated on CHROMAgar Candida Medium (Becton Dickinson ®) and identifi ed by using biochemical, automatic test ID32C (bioMerieux). Susceptibility of the strains to the antifungal agents: amfotericin B, itraconazol, fl uconazol, voriconazol was tested using E-test (AB Biodisk) on RPMI agar plates (Biolife®). Results: The positive cultures were obtained in 662 samples from 402 patients receiving immunosuppressive therapy. There were cultured 267 isolates of Candida albicans, 223-Candida glabrata, 39 strains of C. parapsilosis, 37 -C. krusei and 35 ofTrichosporon asahii, 20-Saccharomyces cerevisiae, 9 strains of Cryptococcus neoformans 5 -C. lipolytica, 6 strains of C. lusitaniae and 4 of C. sake, 5 strain of C. quilliermondii, 3 -C rugosa and and 9 molds from Aspergillus fumigatus species. From cultured strains 37.3% was naturally fl uconazole resistant and 0.5% amphotericin B resistant. The acquired resistant to fl uconazole was presented by 10 isolates, to itraconazole-26, to voriconazole-2 and to amphotericin B by 3 isolates. Conclusions: 1. The most numerable groups of isolated fungal species in patients after SOT were Candida albicans-40% of all isolates and Candida glabrata-33,7%. 2. Molds were cultured less often and they were found only in 1.4% of positive cultures. 3. More than one third of isolated fungi were re...
Most cardiac tumors are benign and localized to the left atrium. Right atrial myxomas are rare and mostly discovered during symptomatic workup or as an incidental finding. Usually, right atrial myxomas are comparatively asymptomatic compared to their left atrial counterparts and do not embolize to systemic circulation unless associated with other anatomical defects. We report a rare case presenting with a history of fever and diagnosed by transthoracic echocardiography. The myxoma was successfully removed surgically, and the patient has significantly improved clinically since then.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.